Drug Trial Radar · NCT06405607
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Jun 12, 2025
Primary completion
Apr 2028
Study completion Apr 2028
Sponsor
- Lead sponsor
- University of IowaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual psychotherapy sessions plus a 30 mg dose of psilocybin. Arm 2 subjects (n=40) will receive individual psychotherapy sessions and a 0.75 mg/kg dose of ketamine.
Conditions
- Alcohol Use Disorder
- Alcohol Dependence
- Alcohol Abuse
Interventions
PsilocybinDrug
30 mg single dose
KetamineDrug
0.75 mg/kg weight-based single dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Timeline Follow-Back for Alcohol to assess changeTime frame: Weekly, over the course of 16 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Iowa Health Care
Iowa City, Iowa · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.